Review article
Inhaled Medication in Obstructive Pulmonary Disease – Can we Accomplish More?
Neven Tudorić
Full text: croatian pdf 96 Kb
page 207-213
downloads: 252
cite
APA 6th Edition
Tudorić, N. (2021). Inhaled Medication in Obstructive Pulmonary Disease – Can we Accomplish More?. Medicus, 30 (2 Astma i KOPB), 207-207. Retrieved from https://hrcak.srce.hr/264155
MLA 8th Edition
Tudorić, Neven. "Inhaled Medication in Obstructive Pulmonary Disease – Can we Accomplish More?." Medicus, vol. 30, no. 2 Astma i KOPB, 2021, pp. 207-207. https://hrcak.srce.hr/264155. Accessed 5 Jan. 2025.
Chicago 17th Edition
Tudorić, Neven. "Inhaled Medication in Obstructive Pulmonary Disease – Can we Accomplish More?." Medicus 30, no. 2 Astma i KOPB (2021): 207-207. https://hrcak.srce.hr/264155
Harvard
Tudorić, N. (2021). 'Inhaled Medication in Obstructive Pulmonary Disease – Can we Accomplish More?', Medicus, 30(2 Astma i KOPB), pp. 207-207. Available at: https://hrcak.srce.hr/264155 (Accessed 05 January 2025)
Vancouver
Tudorić N. Inhaled Medication in Obstructive Pulmonary Disease – Can we Accomplish More?. Medicus [Internet]. 2021 [cited 2025 January 05];30(2 Astma i KOPB):207-207. Available from: https://hrcak.srce.hr/264155
IEEE
N. Tudorić, "Inhaled Medication in Obstructive Pulmonary Disease – Can we Accomplish More?", Medicus, vol.30, no. 2 Astma i KOPB, pp. 207-207, 2021. [Online]. Available: https://hrcak.srce.hr/264155. [Accessed: 05 January 2025]
Full text: english pdf 96 Kb
page 207-207
downloads: 1.654
cite
APA 6th Edition
Tudorić, N. (2021). Inhaled Medication in Obstructive Pulmonary Disease – Can we Accomplish More?. Medicus, 30 (2 Astma i KOPB), 207-207. Retrieved from https://hrcak.srce.hr/264155
MLA 8th Edition
Tudorić, Neven. "Inhaled Medication in Obstructive Pulmonary Disease – Can we Accomplish More?." Medicus, vol. 30, no. 2 Astma i KOPB, 2021, pp. 207-207. https://hrcak.srce.hr/264155. Accessed 5 Jan. 2025.
Chicago 17th Edition
Tudorić, Neven. "Inhaled Medication in Obstructive Pulmonary Disease – Can we Accomplish More?." Medicus 30, no. 2 Astma i KOPB (2021): 207-207. https://hrcak.srce.hr/264155
Harvard
Tudorić, N. (2021). 'Inhaled Medication in Obstructive Pulmonary Disease – Can we Accomplish More?', Medicus, 30(2 Astma i KOPB), pp. 207-207. Available at: https://hrcak.srce.hr/264155 (Accessed 05 January 2025)
Vancouver
Tudorić N. Inhaled Medication in Obstructive Pulmonary Disease – Can we Accomplish More?. Medicus [Internet]. 2021 [cited 2025 January 05];30(2 Astma i KOPB):207-207. Available from: https://hrcak.srce.hr/264155
IEEE
N. Tudorić, "Inhaled Medication in Obstructive Pulmonary Disease – Can we Accomplish More?", Medicus, vol.30, no. 2 Astma i KOPB, pp. 207-207, 2021. [Online]. Available: https://hrcak.srce.hr/264155. [Accessed: 05 January 2025]
Abstract
Inhaled medication is the basis for effective treatment of asthma and chronic obstructive pulmonary disease. Inhalation using various inhalers enables direct release of the drug into the airways, with in situ action that allows for rapid effect with lower drug dose and fewer overall side effects. The use of inhalers is often compromised by usage errors, which may lead to an absence of pulmonary drug deposition, and ultimately to a notably graver course of the disease and unnecessary costs. This work summarizes the basic postulates of the use of inhaled medication, critical inhaler errors, and the importance of continuous education of patients, in which an educated and motivated physician plays a central role.
Keywords
inhaled medication; asthma; COPD; inhaler; inhalation; patient education; motivated physician
Hrčak ID:
264155
URI
https://hrcak.srce.hr/264155
Publication date:
18.10.2021.
Article data in other languages:
croatian
Visits: 2.895
*